Internal Organ and Musculoskeletal Assessment in Hypothyroidism (HYPOMORPH)
HYPOMORPH
Morphometric Characteristics of Internal Organs and Morphofunctional Status of the Musculoskeletal System in Patients With Hypothyroidism
1 other identifier
observational
500
1 country
1
Brief Summary
This hospital-based observational cross-sectional study aims to investigate the morphometric characteristics of internal organs and the morphofunctional status of the musculoskeletal system in adult patients with previously diagnosed hypothyroidism. The study will evaluate ultrasonographic morphometric characteristics of the liver, pancreas, and kidneys, as well as anthropometric and functional characteristics of the musculoskeletal system. Associations between these outcomes and clinical characteristics, anthropometric parameters, physical activity, and laboratory findings will also be assessed. The study is expected to identify accessible clinical, anthropometric, and functional markers associated with morphometric and musculoskeletal changes in patients with hypothyroidism, thereby improving risk assessment and early detection of systemic involvement.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P75+ for all trials
Started Aug 2026
Typical duration for all trials
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
First Submitted
Initial submission to the registry
July 8, 2026
CompletedFirst Posted
Study publicly available on registry
July 16, 2026
CompletedStudy Start
First participant enrolled
August 1, 2026
CompletedPrimary Completion
Last participant's last visit for primary outcome
December 31, 2027
ExpectedStudy Completion
Last participant's last visit for all outcomes
December 31, 2028
July 16, 2026
July 1, 2026
1.4 years
July 8, 2026
July 14, 2026
Conditions
Keywords
Outcome Measures
Primary Outcomes (4)
Liver Longitudinal Diameter
The longitudinal diameter of the liver will be measured by abdominal ultrasonography according to the standardized study protocol. The measurement will be recorded in centimeters (cm).
Baseline
Pancreatic Head Thickness
The anteroposterior thickness of the pancreatic head will be measured by abdominal ultrasonography according to the standardized study protocol. The measurement will be recorded in millimeters (mm).
Baseline
Kidney Length
The longitudinal length of each kidney will be measured by ultrasonography according to the standardized study protocol. Measurements will be recorded in millimeters (mm).
Baseline
Handgrip Strength
Muscle strength will be assessed using a calibrated handgrip dynamometer. Maximum grip strength will be recorded in kilograms (kg). Higher values indicate greater muscle strength.
Baseline
Secondary Outcomes (4)
Five Times Sit-to-Stand Test
Baseline
Body Mass Index
Baseline
Waist Circumference
Baseline
Calf Circumference
Baseline
Study Arms (1)
Patients With Hypothyroidism
Adult patients with a previously established diagnosis of hypothyroidism who will undergo clinical examination, anthropometric assessment, ultrasonographic evaluation of the liver, pancreas and kidneys, functional assessment of the musculoskeletal system, and laboratory testing according to the study protocol.
Interventions
Participants will undergo a standardized diagnostic assessment including clinical evaluation, anthropometric measurements, ultrasonographic examination of the liver, pancreas, and kidneys, functional
Eligibility Criteria
Adult patients with a previously established diagnosis of hypothyroidism receiving routine medical care at participating healthcare institutions.
You may qualify if:
- Adults aged 18-59 years.
- Previously established diagnosis of hypothyroidism.
- Receiving routine outpatient or inpatient care at participating healthcare institutions.
- Ability to undergo ultrasonographic, anthropometric, and functional assessments.
- Provision of written informed consent.
You may not qualify if:
- Pregnancy or lactation.
- History of thyroid malignancy.
- Acute infectious or inflammatory disease at the time of enrollment.
- Severe decompensated cardiovascular, hepatic, or renal disease preventing study procedures.
- Neurological or musculoskeletal disorders that preclude functional testing.
- Refusal or inability to provide informed consent.
- Incomplete clinical or laboratory data.
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Study Sites (1)
Andijan State Medical Institute
Andijan, 170127, Uzbekistan
MeSH Terms
Conditions
Condition Hierarchy (Ancestors)
Central Study Contacts
Study Design
- Study Type
- observational
- Observational Model
- COHORT
- Time Perspective
- CROSS SECTIONAL
- Sponsor Type
- OTHER
- Responsible Party
- SPONSOR
Study Record Dates
First Submitted
July 8, 2026
First Posted
July 16, 2026
Study Start
August 1, 2026
Primary Completion (Estimated)
December 31, 2027
Study Completion (Estimated)
December 31, 2028
Last Updated
July 16, 2026
Record last verified: 2026-07